Treatment | Dysplasia | Adenoma | Adenocarcinoma | Tumora |
---|---|---|---|---|
Non-treatment | 0% (0/8) | 0% (0/8) | 0% (0/8) | 0% (0/8) |
Vehicleb + 4% DSS | 0% (0/13) | 0% (0/13) | 0% (0/13) | 0% (0/13) |
AAT (125 mg/kg/day) | 0% (0/6) | 0% (0/6) | 0% (0/6) | 0% (0/6) |
AAT (125 mg/kg/day) + 4% DSS | 75% (6/8)*** | 100% (8/8)*** | 100% (8/8)*** | 100% (8/8)*** |
DMBA (25 mg/kg/day) | 0% (0/5) | 0% (0/5) | 0% (0/5) | 0% (0/5) |
DMBA (25 mg/kg/day) + 4% DSS | 50% (3/6)** | 50% (3/6)** | 50% (3/6)** | 83% (5/6)*** |
ENU (11 mg/kg/day) | 0% (0/6) | 0% (0/6) | 0% (0/6) | 0% (0/6) |
ENU (11 mg/kg/day) + 4% DSS | 100% (7/7)*** | 100% (7/7)*** | 100% (7/7)*** | 100% (7/7)*** |